GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Zura Bio Ltd (STU:94E) » Definitions » Other Current Receivables

Zura Bio (STU:94E) Other Current Receivables : €0.00 Mil (As of Sep. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Zura Bio Other Current Receivables?

Zura Bio's Other Current Receivables for the quarter that ended in Sep. 2024 was €0.00 Mil.


Zura Bio Other Current Receivables Historical Data

The historical data trend for Zura Bio's Other Current Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zura Bio Other Current Receivables Chart

Zura Bio Annual Data
Trend Dec21 Mar22 Dec23
Other Current Receivables
- - -

Zura Bio Quarterly Data
Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Other Current Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Zura Bio Other Current Receivables Calculation

GuruFocus uses a standardized financial statement format for all companies. GuruFocus lists Accounts Receivable, Notes Receivable , Loans Receivable and Other Current Receivables under the "Total Receivables" section.


Zura Bio Other Current Receivables Related Terms

Thank you for viewing the detailed overview of Zura Bio's Other Current Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.


Zura Bio Business Description

Industry
Traded in Other Exchanges
Address
1489 W. Warm Springs Road, Suite 110, Henderson, NV, USA, 89014
Zura Bio Ltd is a multi-asset clinical-stage biotechnology company focused on developing novel medicines for immune and inflammatory disorders.

Zura Bio Headlines

No Headlines